Announcements Trials

Browse Landscape

Phase

Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 4 Gynecologic 1

Conditions

Endometrial Neoplasms 1 Breast Neoplasms 1

Interventions

Paclitaxel 108 Carboplatin 97 pembrolizumab 64 Cisplatin 63 Cyclophosphamide 45 Bevacizumab 35 Taxes 31 Gemcitabine 28 liposomal doxorubicin 27 Topotecan 26 fludarabine 25 olaparib 22 Nivolumab 20 Docetaxel 20 Radiotherapy 18 Brachytherapy 17 veliparib 16 Magnetic Resonance Spectroscopy 16 Doxorubicin 16 Biopsy 15 Radiation 14 niraparib 13 aldesleukin 13 Specimen Handling 13 Platinum 13 Oxaliplatin 13 Filgrastim 13 Albumin-Bound Paclitaxel 12 atezolizumab 11 Interleukin-2 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Imlunestrant × Gynecologic × Clear all

NCT04188548 2025-06-04

EMBER

Eli Lilly and Company

Phase 1 Active not recruiting

BreastGynecologic

Breast Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡